Biocon profit at Rs 147 cr, revenue up 21%: @ Long Term Investment Report by Stock Expert

India’s largest Biotechnology company, Biocon, reported September quarter profit raised 52 per cent to Rs 146.7 crore against Rs 97 crore in the same period last year, on improved business growth across small molecules, biologics and research services. The second quarter profit in FY16 is before exceptional items.

Long Term Investment Calls by Expert

Biocon Ltd : Buy Biocon at around 880 to 885 with targets 915,  935 With Stop Loss 841. You can hold 1 month.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s